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Human Hence Jones protein toxicity in rat proximal tubule epithelium
in vho. To investigate the direct toxicity of human Bence Jones protein
(BJP), individual nephrons of male Sprague-Dawley rats were perfused
in vivo at 20 nl/min with an artificial tubule fluid (ATF) that contained
no protein, a human kappa BJP (5 gIdl), or bovine serum albumin (5
gIdl), and proximal convoluted tubule function and morphology were
examined. Perfusion with BJP perfusate for 5 minutes produced no
changes (P = NS) in absorption of water, J,,, (1.09 0.20 vs. 1.50
0.25 nI/mm/mm), chloride, Jci, (95 47 vs. 123 41 pEq/min/mm), and
glucose, J0, (39 3 vs. 40 5 pmol/min/mm) compared to perfusions
with only ATF. However, perfusion for at least 20 minutes with the
same BJP perfusate produced decreased (P < 0.025) in J (0.58 0.12
vs. 1.15 0.14 nI/mm/mm) and J0 (27 3 vs. 38 3 pmol/min/mm)
compared to perfusions with ATF alone; the decrease in Jci (64 47 vs.
119 27 pEq/min/mm) did not reach statistical significance. Perfusion
for 20 minutes with ATF containing albumin resulted in no changes in
J (1.22 0.21 vs. 1.15 0.14 nI/mm/mm), Jci (207 29 vs. 119 27
pEq/mmn/mm), and J0 (31 1 vs. 38 3 pmol/minlmm), when com-
pared to the ATF perfusions. Immunocytochemistry, immunofluores-
cence and immunoelectron microscopy of the BJP-perfused tubules
demonstrated the kappa light-chain protein in endosomes and activated
lysosomes. In addition, cellular desquamation and fragmentation, prom-
inent cytoplasmic vacuolation, and focal loss of the microvillus border
were found in the BJP-perfused tubules, but not in the albumin-perfused
tubules. In conclusion, these functional and morphologic data show that
a human kappa light-chain is toxic to the proximal convoluted tubule of
the rat. This toxicity occurred in a time-dependent fashion when the
lysosomal system was markedly activated. Direct damage of the tubule
epithelium by BJP's may be involved in the development of the
tubulointerstitial nephropathy associated with multiple myeloma.
Renal failure is a major complication of multiple myeloma,
occurring in about half of the patients with this disease; its
appearance is associated with a markedly-shortened patient
survival [1—3]. Although several different renal lesions may
develop, the most commonly recognized is a tubulointerstitial
nephropathy often referred to as "myeloma kidney" [3]. This
tubule damage may develop insidiously or acutely [4] and is
usually associated with the presence of urinary Bence Jones
proteins (BJP) [4—6], which consist of immunoglobulin light
chains in monomeric, dimeric, and aggregate forms [7]. Several
studies from our laboratory [8, 9] and others [10—131 have
shown that both acute and chronic exposure of kidneys of
experimental animals to BJP's can produce tubule damage that
histologically resembles the human disease [8]. The pathoge-
netic mechanism(s) of this toxicity of BJP's is undetermined,
but there are currently at least two postulated processes of
tubule injury: direct toxicity to the epithelial cells of the neph-
ron and intratubular obstruction [14]. These mechanisms are
not mutually exclusive and may produce renal damage in
concert. Using in vivo single nephron perfusion in the rat and
light, electron and immunofluorescence microscopy, this study
investigates the hypothesis that human BJP's are directly toxic
to the epithelium of the proximal convoluted tubule.
Methods
Animal preparation
The preparation for micropuncture was similar to the method
described previously [15]. Male Sprague-Dawley rats (Charles
River Breeding Laboratories, Inc., Wilmington, Massachu-
setts, or Taconic Farms, Inc., Germantown, New York, USA),
which weighed 230 to 360 g and were maintained on standard rat
chow (Agway/Prolab 1000, Syracuse, New York, USA) and tap
water ad libitum, were anesthetized with thiobutabarbitol (In-
actin, Promonta, Hamburg, FRG), 100 mg/kg body weight
(body wt), intraperitoneally. After placement on a servo-con-
trolled heated table, tracheostomy was performed with PE-240
polyethylene tubing followed by insertion of a right external
jugular line using PE-50 tubing. Ringer-bicarbonate (0.15 M)
with 2% polyfructosan (mutest, Laevosan, Linz, Austria) was
infused at 2.0 ml/100 g body wt/hr after a 1 ml bolus. The right
femoral artery was cannulated to monitor arterial pressure and
to sample blood. The bladder was catheterized with PE-50
tubing for urine collections. The left kidney was exposed
through a subcostal incision and, after separation from the
perirenal fat and adjacent adrenal gland, was placed in a
Lucite® cup. A well was formed on the surface of the kidney
with 4% agar and was filled with water-equilibrated mineral oil.
Microperfusion protocol
Received for publication December 10, 1986
and in revised form June 1, 1987
© 1987 by the International Society of Nephrology
851
Approximately one hour after the intravenous infusion was
started, arterial blood samples were collected for the determi-
nation of hematocrit, osmolality, and plasma sodium, potas-
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sium, chloride, and protein concentrations. The micropuncture
period was then begun. A pipette filled with an artificial tubule
fluid (ATF) was inserted into an early surface, proximal con-
voluted tubule (PCT) segment and a small bolus of fluid outlined
the nephron. The ATF contained (in mM): 100 NaC1, 25
NaHCO3, 5 KC1, 0.6 CaCI2, 3.1 NaH2PO4, 14.5 Na2HPO4, 5
D-glucose; this fluid was tinted with Food, Drug and Cosmetic
(FD&C) Green #3 (Keystone Aniline and Chemical Co., Chi-
cago, Illinois, USA). A pipette filled with bone wax was
inserted into the earliest accessible surface proximal convolu-
tion and a small cast 4 to 5 tubule diameters in length was
injected into the tubule with a microdrive unit (Trent Wells,
South Gate, California, USA). A pipette attached to a
microperfusion pump (W-P Instruments, Inc., New Haven,
Connecticut, USA) was inserted into the tubule just distal to the
wax block and the remaining nephron was perfused at 20
nI/mm. The composition of the perfusion solutions was the
same as described above except for the addition of [3H]-
methoxyinulin (269.5 mCi/g, New England Nuclear, Boston,
Massachusetts, USA), which had been extensively dialyzed
against distilled water, and a trace amount of D-['4C]glucose
(257.7 mCilmmol, New England Nuclear). The experimental
perfusate contained a human BJP, 5 gIdl. This concentration of
BJP is in excess of the reported range of serum BJP concentra-
tion in humans who have multiple myeloma and renal failure
(0.3 to 3.2 g/dl) [8, 16], but was chosen to enhance the
possibility of detection of toxicity since the contact time (perfu-
sion duration) was relatively short. The final pH of each
perfusion solution was adjusted to 7.40 by bubbling a mixture of
95% 02/ 5% CO2 into the solution just before aspiration of the
fluid into the perfusion pipette. Mter perfusion of the tubule for
either 5 or 20 minutes, a collection pipette filled with tinted
mineral oil was inserted into the latest accessible, surface
proximal convolution, a mineral oil block was injected, and a
complete timed collection of tubule fluid was made for three to
five minutes. We perfused the maximum available length of
surface-proximal convoluted tubule, so the earliest to latest
accessible surface convolutions were micropunctured with
perfusion and collection pipettes, respectively. One to three
perfusions were obtained in each animal. After the collections
were complete, the perfused segments were injected with
Microfil (Canton Bio-Medical Products, Inc., Boulder, Colo-
rado, USA), the kidney was removed and dissolved in 25%
NaOH, and the perfused segments were dissected and their
lengths measured directly with a micrometer scale.
Five different groups of perfused nephrons were studied. The
first experimental group (BJP5) of nephrons and a correspond-
ing control group (ATF5) were perfused for five minutes or less.
The other three groups consisted of: 1) an experimental group
(BJP2O) of perfusions that used ATF containing the BJP; 2)
another group (ALB2O) that consisted of tubules perfused using
ATF that contained albumin (bovine albumin, fraction V, purity
>96%, Sigma Chemical Co., St. Louis, Missouri, USA), that
had been prepared similarly to the BJP and was present in the
same concentration, 5 g/dl; and 3) control perfusions (ATF2O)
that used ATF alone. These groups were perfused for 20
minutes and differed from the first two groups only in the
duration of perfusion before which the tubule fluid samples
were obtained. The ALB2O group served as a control for the
presence of intraluminal protein.
During the microperfusion period, two 30-minute inulin clear-
ances were determined and, at the completion of micropunc-
ture, arterial blood was sampled for determination of hemato-
crit, osmolality, and plasma sodium, potassium, chloride, pro-
tein, and glucose concentrations. Rats were considered unsuit-
able for study if the arterial pressure fell below 100 mm Hg or if
the inulin clearance was less than 500 j.d/min. Tubule perfusions
were accepted for study if they had: 1) calculated perfusion
rates between 15 and 23 nI/mm, 2) collectate to perfusate inulin
ratios  1.0, and 3) perfused tubule lengths between 0.7 and 4.0
mm.
Morphologic and immunocytochemical studies
Histologic examination of individual in vivo perfused neph-
rons was performed. In these experiments, a single inulin
clearance and packed cell volume were collected during the
microperfusion period. Control and experimental perfusates
contained albumin, 5 g/dl, or BJP, 5 g/dl, respectively. These
perfusates were similar to those used in the microperfusion
experiments except for omission of the [3H]-methyoxyinulin
and D-['4C]glucose. After perfusion of the nephron distal to the
wax block with either control or experimental perfusate for
approximately 20 minutes, the tubules were perfused immedi-
ately for three to four minutes with Carson-Millonig's solution,
pH 7.0, that was tinted with filtered India ink (Faber-Castell
Corp., Lewisburg, Tennessee, USA). In each experiment, two
tubules were perfused with either control or experimental
perfusates, the order of which was alternated daily. The animals
were then sacrificed, the perfused tubules were partially dis-
sected, and the remaining tissue placed in untinted Carson-
Millonig's solution, pH 7.0. The India ink was not removed by
the fixation procedure and therefore allowed accurate identifi-
cation of the nephron that had been perfused. The tissue was
processed for light microscopy in standard fashion and was
embedded in paraffin (Ameraffin, Stephens Scientific, Oak
Ridge, New Jersey, USA) for sectioning. The specimens were
trimmed until the nephron that contained the India ink was
identified. Successive 3 sections were cut with a microtome
(Reichert Jung, Buffalo, New York, USA) and stained with
hematoxylin and eosin (H&E) for light microscopy or with an
avidin-biotin complex (ABC) method that used anti-kappa or
anti-lambda antibodies, dilution 1/5000 (Accurate Chemical and
Scientific Corp. [Dakopatts], Westbury, New York) [17]. This
process was continued until the nephron was sectioned com-
pletely.
In another group of experiments, after perfusion of a single
nephron with the BJP solution for 20 minutes, this nephron was
perfused for three to four minutes With FD&C tinted ATF that
did not contain BJP, so that excess BJP remaining in the lumen
of the nephron was removed. The animal was sacrificed and the
perfused nephron was rapidly dissected and immediately em-
bedded in Tissue-Tek Optimum Cutting Temperature com-
pound (Miles Laboratory, Naperville, Illinois,USA) and snap-
frozen in liquid nitrogen. The tissue was mounted, and 3 /Lserial
sections of the entire perfused nephron were carefully made and
stained with fluorescein isothiocyanate-labeled anti-kappa or
anti-lambda antisera (Accurate Chemical and Scientific Corp).
In the final series of experiments, after perfusion for 20
minutes with either control (albumin) or experimental (BJP)
solutions, the tubules were immediately perfused for three to
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four minutes with either FD&C tinted, phosphate-buffered, 2%
glutaraldehyde solution, pH 7.3, or FD&C tinted, Carson-Mi!-
lonig's solution, pH 7.0. Both fixatives also contained either 15
or 40 nm colloidal-gold particles (Janssen Pharmaceutica N.Y.,
Beerse, Belgium) which served as a marker for ultrastructural
identification of the perfused tubule. One control and experi-
mental tubule were obtained in each experiment; their order
was alternated daily. The rat was sacrificed and the tubules
partially dissected and placed in either untinted, phosphate-
buffered, 2% glutaraldehyde solution, pH 7.3, or untinted
Carson-Millonig's solution, pH 7.0, until preparation for elec-
tron microscopy. After initial fixation, the samples were post-
fixed in 1% osmium tetroxide (Electron Microscopy Sciences,
Fort Washington, Pennsylvania, USA) and embedded either in
araldite resin (Electron Microscopy Sciences) or L,R. White
resin (Polysciences Inc., Fort Valley, Pennsylvania USA).
Thick sections of the plastic-embedded material were stained
with toluidine blue (Fisher Scientific Co., Fair Lawn, New
Jersey, USA) for light microscopy survey. Ultrathin sections
were postcontrasted with uranyl acetate and lead citrate (Fisher
Scientific Co.). Sections that were embedded in the L.R. White
resin were not post-fixed. After fixation, they were washed
briefly in Tris buffer, pH 7.6, and were blotted. They were then
processed through several solutions of increasing concentra-
tions of ethyl alcohol: 15 minutes in 60%, 15 minutes in 80%,
and 20 minutes in 95% (2 exchanges). In order to avoid
excessive shrinkage, the tissues were also incubated in a 2:1
mixture of L.R. White/95% ethanol for one hour at room
temperature. Following these procedures, the specimens were
blotted and infiltrated with pure L.R. White resin overnight at
4°C. The tissues were then incubated for one hour in fresh resin,
allowing further infiltration of the tissues, and the resin was
polymerized over 18 to 24 hours at 50°C (temperatures greater
then 60°C were avoided). The specimens were examined with a
transmission electron microscope (Model H-600, Nissei Sangyo
America, Ltd., Hitachi Scientific Instruments, Tokyo, Japan).
The perfused tubules were identified by the presence of the
colloidal gold in their lumens.
Tissue for immunoelectron microscopy was prepared using
two indirect immunogold staining procedures that utilized sim-
ilar methodologies [18, 19]. In the first method, osmicated
ultrathin sections in the araldite/epon resin were cut from the
block and collected on uncoated 300 mesh nickel grids (Elec-
tron Microscopy Sciences) and dried overnight at room temper-
ature. Grid-mounted sections were etched in 10% hydrogen
peroxide for 10 minutes, washed in distilled water for five
minutes, and then incubated at room temperature in normal
goat serum (Vector Laboratories, Inc., Burlingame, California,
USA), 1:30 dilution in 0.05 M Tris-buffered saline (TBS), for 30
minutes. The grids were then incubated with polyclonal anti-
bodies to kappa and lambda light chains (Accurate Chemical
and Scientific Corp.) 1:1000 and 1:2000 dilutions in TBS, for 48
hours at 4°C, and then washed twice in TBS and once in TBS
that contained 1% BSA, 10 minutes each. The grids were then
incubated for one hour at room temperature in gold-labeled
goat, anti-rabbit IgG serum (Janssen Pharmaceutica N.Y.), 1/15
in 0.02 M TBS containing 1% BSA, pH 8.2. The samples were
again washed twice in TBS and twice in distilled water, 10
minutes each. The sections were counterstained with uranyl
acetate and lead citrate, Sections of the control tubules were
processed similarly. The second indirect immunogold staining
technique used tissue that was fixed in the Carson Millonig's
solution and embedded in the L.R. White resin. This method
was very similar to the first, except that the tissue was not
osmicated and was not etched with hydrogen peroxide. In
addition, the tissue was incubated with polyclonal antibodies to
kappa and lambda light chains, 1:1000 and 1:2000 dilutions, for
only 16 hours.
BJP preparation
Using standard techniques, the protein was isolated from the
urine of a patient who had had multiple myeloma and renal
failure. Initially, ammonium sulfate was added to the urine to
achieve a 70% saturation. The precipitate was redissolved in
distilled water and then dialyzed at least 24 hours using cellu-
lose dialysis tubing (Spectrapor Membrane Tubing, Fisher
Scientific) that had a 12,000 to 14,000 dalton cutoff, against
distilled water and then 0.01 M sodium phosphate buffer, pH
7.6. Ion exchange chromatography using a 2.5 x 30 cm DEAE-
52 column that had been equilibrated in 0.01 M sodium phos-
phate buffer, pH 7.6, was then employed to further purify the
BJP. The protein was desalted with a G-10 column and lyoph-
ilized. Immunoelectrophoresis confirmed that the BJP was a
kappa light chain. Purity of the protein was shown to be greater
than 95% by electrophoresis on 7 to 209o polyacrylamide
gradient slab-gels containing 0.1% sodium dodecyl sulfate
(SDS-PAGE), using the discontinuous buffer system described
by Laemmli [20]. The majority of the protein consisted of
monomeric and dimeric forms that had molecular weights of
23,400 and 46,800, with only a small fraction present as aggre-
gates. In addition, prior to use, the protein was dialyzed
extensively against distilled water at 4°C using cellulose dialysis
tubing. The isoelectric point of the kappa light chain was
determined using the standard techniques described in the LKB
Application Note 250.
Analytical methods
Hematocrit was estimated with a microhematocrit capillary
tube reader (Spiracrit, Lancer, St. Louis, Missouri, USA).
Plasma sodium and potassium concentrations were determined
with a flame photometer (Model IL-943, Instrumentation Lab-
oratories, Inc.). Plasma chloride concentration and osmolality
were determined arnperometrically (Buehler digital chloridom-
eter, Buehler Instruments, Inc., Fort Lee, New Jersey, USA)
and by vapor pressure osmometry (Wescor, Inc., Logan, Utah,
USA), respectively. Plasma protein concentration was deter-
mined by refractometry (American Optical Corp., Buffalo, New
York, USA). Values obtained at the start and completion of the
micropuncture period were averaged for each rat. Inulin con-
centration in urine and plasma samples was determined using
the anthrone colorimetric method [211. Clearance of inulin (C111)
was calculated from these values and was factored by body
weight. Plasma glucose concentration was determined by the
glucose oxidase method on a model SBA-300 batch analyzer
(Gilford Co., Oberlin Ohio, USA).
The volume of fluid collected from the PCT was measured
using constant bore glass tubing and a microslide comparator
(Gaertper Scientific Corp., Chicago, Illinois, USA). Chloride
concentrations of the perfusate and collectate samples were
determined by electrometric titration [22] (model FT-2230
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Table 1. Characteristics of the perfusion groups
Group
Perfusion
rate
nI/mm
Tubule
length
mm
Perfusate
chloride
mEq/li:er
Perfusate
osmolality
mOsm/kg
BJP5 18.8 0.8 1.3 0.1 107 1 302 2
ATF5 20.1 0.6 1.7 0.3 107 2 292 5
P value NS NS NS NS
ATF2O 18.6 0.5 1.6 0.2 104 1 299 4
BJP2O 18.5 0.8 2.0 0.3 104 1 307 I
P valuea NS NS NS NS
ALB20 19.0 0.5 1.9 0.2 104 1 288 4
P valueb NS NS NS NS
a Comparison of data of the BJP2O and ATF2O groupsb Comparison of data of the ALB2O and ATF2O groups
microtitrator, W-P Instruments, Inc., New Haven, Connecti-
cut, USA). Osmolalities of the nanoliter samples were deter-
mined by freezing point depression (nanoliter osmometer,
Clifton Technical Physics, Hartford, New York, USA). The
[3H] and [14C] activities of measured volumes of the collected
samples and perfusate were determined using a liquid scintilla-
tion counter (Model 6892, Tracor Analytic, Elk Grove Village,
Illinois, USA). In vivo microperfusion rate (PR) was calculated
as (in ni/mm):
PR = CR x [3HJ/[3H1
where CR is the collectate volume divided by collection time;
[3H], the [3H] activity of the collectate; and [3H19, the [3H1
activity of the perfusate.
Volume absorption (J) was calculated as (in nl/min/mm
tubule length):
J.. (PR — CR)/L
where L is the length of the perfused segment.
Chloride absorption (Jc1) was calculated as (in pEq/minlmm
tubule length):
Jci = {(P1 X PR) — (Cc1 X CR)}/L
where P1 is the perfusate chloride concentration and CCI is the
collectate chloride concentration.
Glucose absorption (JG) was calculated as (in pmol/minlmm
tubule length):
= {(['4CJ x PR) — (['4C] x CR)/(['4CJ
XPR)XL}xPRxPG (4)
where [14CJ is ['4C] activity of the perfusate; [14C] is ['4C]
activity of the collectate; and P6 is the perfusate glucose
concentration (in pmollnl).
Statistical analysis
All values are given as mean SEM. Comparisons between
two groups were analyzed for statistical significance by the
unpaired t-test, with significance set at the 5% level. For
comparisons among three groups, the Bonferróni modification
of the I-test was used, with significance set at the 2.5% level.
Results
Microperfusion experiments
Mean systemic variables of the 34 rats used in this portion of
the study were: hematocrit, 44 1%; plasma sodium, 150 1
Table 2. Absorption characteristics of the perfusion groups
Group
Number of
perfusions/
rats
Volume
absorption
ni/mm/mm
Chloride
absorption
pEq/min/mm
Glucose
absorption
pmoI/min/mm
BJP5 11/6 1.09 0.20 95 47 39 3
ATF5 8/5 1.50 0.25 123 41 40 5
P value NS NS NS
ATF2O 18/13 1.15 0.14 119 27 38 3
BJP2O 9/8 0.58 0.12 64 43 27 3
P valuea <0.025 NS <0.025
ALB2O 15/10 1.22 0.21 207 29 31 1
P valu&' NS NS NS
a Comparison of data of the BJP2O and ATF2O groups
b Comparison of data of the ALB2O and ATF2O groups
mEq/liter; plasma potassium, 4.9 0.1 mEq/liter; plasma
chloride, 104 1 mEq/liter; plasma osmolality, 308 1
mOsm/kg; plasma protein, 4.7 0.1 gldl; and plasma glucose,
7.6 0.3 mmollliter. The urine flow rate and inulin clearance
were 5.2 0.7 .d/min/100 g body wt and 948 64 d/minh10O g
body wt. Mean arterial pressure was 119 1 mm Hg. Calcu-
lated perfusion rate, length of the perfused segment of proximal
convoluted tubule, and perfusate chloride concentration and
osmolality were not different between each experimental and
(1) corresponding control group (Table 1). The isoelectric point of
the kappa light chain used in the experiments was 7.7.
In proximal convoluted tubules (PCT's) perfused for 5
minutes, absorptions of water (J), chloride (Jci), and glucose
(J0) did not differ between control (ATF5) and experimental
(BJP5) perfusions (Table 2). However, in those PCT's perfused
for 20 minutes with perfusate that contained BJP (BJP2O), 2,,,
(2) and J0 were less (P <0.025) than the corresponding values of
PCT's perfused for 20 minutes with ATF alone (ATF2O). The
decrease in Jci did not reach statistical significance. Tubules
perfused for 20 minutes with albumin (ALB2O) in the perfusate
showed no changes in J,,,, Jci and J0 compared to control
(3) (ATF2O) perfusions; this lack of effect of a high luminal con-
centration of albumin on J,,, agrees with Green, Windhager, and
Giebisch [231. To summarize, perfusion with BJP produced
time-dependent decreases in 2.,, and JG in the PCT in vivo; these
decreases did not occur in tubules perfused for similar durations
with albumin at the same concentration.
Morphologic and immunocytochemical studies
Inulin clearance averaged 844 71 td/min/lOO g body wt and
the mean arterial pressure was 124 3 mm Hg in the 15 animals
used in these studies. On light microscopic examination, the
albumin-perfused tubules (N = 4) were normal in appearance,
except for rare epithelial cell vacuolation in one tubule. In
contrast, none of the BJP-perfused tubules (N = 4) had normal
morphology. All four nephrons had mild to moderate vacuola-
tion of the epithelium with desquamation of tubule cells noted in
three tubules (Fig. 1). With the ABC technique, kappa light
chains were identified in the tubule lumen and in discrete areas
of the cytoplasm of the PCT cells (Fig. 2). In separate experi-
ments (N 2), immunofluorescence microscopy also showed
kappa staining in the lumen and within the cells of the PCT;
lambda staining was negative.
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Fig. 1. Comparison of a BJP-perfused PCT (A) with an albumin-perfused PCT (B), both of which are identified by the India ink (dark particles)
in the lumen (L). Desquamation of epithelial cells (curved arrows) and mild vacuolation (arrows) of the lining PCT cells (E) are seen in the
BJP.perfused tubule. In contrast, the albumin-perfused tubule (B), surrounded by arrows, is normal in appearance. (H&E stain, original
magnification x 240).
Electron microscopy (N = 7) demonstrated prominent vacu-
olation of the epithelium of the BJP-perfused PCT's and
lysosomes that were more numerous and enlarged compared to
the albumin-perfused tubules (N = 4) (Figs. 3 and 4A). Some of
the lysosomes were markedly enlarged, distorted and atypical
in appearance; structures resembling crystals were occasionally
identified in the lysosomes (Figs. 4B and 5). In addition, cellular
desquamation was seen in six of the seven BJP-perfused tubules
and was absent in control tubules (Figs. 3 and 6A). Focal loss of
the microvillus border of several cells of the PCT's was
demonstrated only in the experimental perfusions (Figs. 4A and
6B). Immunoelectron microscopy, using anti-kappa antibody
that was linked to colloidal gold, confirmed the presence of the
BJP in the lumen and in endosomes and lysosomes of the cells
of the PCT (Figs. 5 and 6). The surrounding tubules, intersti-
tium and mitochondria of these tubules (Fig. 6) and albumin-
perfused nephrons did not show significant labeling with the
anti-kappa antibody and the BJP-perfused tubules did not stain
with the anti-lambda antibody. Thus, both light and electron
microscopy techniques showed uptake of the kappa BJP into
the epithelium of the PCT and alterations in morphology
compatible with acute epithelial cell-injury after 20 minutes of
perfusion in vivo; morphologic alterations of PCT damage were
not seen in albumin-perfused tubules.
Discussion
These data show that: (1) proximal convoluted tubules (PCT)
of the rat absorb human Bence Jones protein (BJP) by
endocytosis; (2) BJP is localized in endosomes and lysosomes
of the PCT; (3) in proximal convoluted tubules (PCT's) perfused
with BJP, Jv and JG decrease in time-dependent fashion; and (4)
morphologic evidence of damage of the PCT is present after
perfusion with BJP but not albumin.
The kidney is an important site of uptake and catabolism of a
variety of low molecular-weight proteins that include immuno-
globulin light chains (mol wt about 22,000), albumin, comple-
ment protein D, lysozyme, insulin, growth hormone, parathy-
roid hormone, and glucagon [15, 23—31]. Proteins that are
filtered by the glomerulus are absorbed primarily by the prox-
imal tubule [29, 31], although epithelia of other segments of the
nephron have been shown to absorb protein [32, 331. With the
exception of small peptides, such as bradykinin and angiotensin
II, that undergo hydrolysis along the luminal membrane of the
proximal tubule cells, proteins are absorbed by endocytosis and
can be found initially in endosomes that fuse subsequently with
lysosomes, allowing hydrolysis of the absorbed proteins to
amino acids in an acidic environment [29, 31]. Our findings
show that rat PCT cells absorb human BJP which was identified
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Fig. 2. Usingan avidin-biotin complex (ABC) immunostaining method, the presence of the kappa light chain in the tubule lumen (L) and in discrete
areas of the cytoplasm (curved arrows) of a BJP-perfused PCT is shown. Mild cellular desquamation (arrow) is apparent; the desquamated cells
also contained kappa light chain. E represents lining epithelial cells. (ABC stain, original magnification X240).
within the endosomes and lysosomes of the PCT (Figs. 5 and 6)
and are consistent with the mechanism of renal handling of low
molecular-weight proteins.
Clinical evidence suggests this process of BJP absorption and
catabolism may also injure the kidney. In patients with multiple
myeloma and myeloma kidney, atrophy of the proximal tubule
has been shown to correlate with the degree of renal failure
better than cast formation [5]. In the same study, patients with
Bence Jones proteinuria and multiple myeloma had a higher
incidence of renal failure and more defects in urine acidification
and urine concentrating ability than those patients who had
multiple myeloma but no Bence Jones proteinuria. Finally,
proximal tubule damage in the form of Fanconi syndrome has
been recognized as a complication of Bence Jones proteinuria;
renal histology of these patients frequently showed destruction
and electron-dense, needle-like crystals in the cytoplasm of the
proximal tubule cells [34].
Experimental evidence of a direct cellular toxicity of BJP's
has been suggested by Preuss et al, who demonstrated that rat
kidney slices incubated for four hours with crude extracts of
BJP, 1.0 g/dl, had impaired cellular gluconeogenesis, ammonia-
genesis, and hippurate uptake compared to control kidney
slices incubated with protein extracts from the urine of patients
with nephrotic syndrome [35]. However, these results could not
be verified in a similar experiment that used a more purified
form of BJP [36]. Also, the use of renal cortical slices to study
cellular transport and metabolism is controversial because of
studies that have shown that the tubule lumens are collapsed or
occluded [37] and oxygen delivery is inadequate to maintain
metabolic processes in these preparations [38]. More recently,
Batuman et al showed that BJP decreased glucose absorption
by proximal tubule, brush border vesicles in 30 seconds [39].
The osmolalities of the solutions that contained the BJP's were
not reported.
Our in vivo microperfusion study showed that diminished
volume and glucose absorption by the PCT, the major site of the
BJP absorption, occurred in a time-dependent fashion after
luminal exposure to the BJP in a concentration of 5 g/dl. In
preliminary studies, it was noted that the addition of BJP, which
had been prepared by standard methods, increased the osmolal-
ity of ATF (D. W. Barfuss, personal communication). These
osmotically active substances are usually electrolytes that are
acquired during the protein isolation techniques. Our prepara-
tion of the BJP's completely removed these substances since
the addition of dialyzed BJP, 5 g/dl, did not change perfusate
osmolality. Such small osmotic activities may profoundly alter
fluid movement in sensitive test systems, such as tissue slices
and membrane vesicle preparations [40]. Thus, the discrepancy
between our study and that of Batuman et al [391,regarding the
time-dependent nature of the defect in JG, may be due to the
.1;
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Fig. 3. Electronmicrograph of a BJP-perfused tubule (A) and an albumin-perfused tubule (B). The BJP-perfused proximal tubule (A) has an
activated lysosomal system (arrows), prominent apical vacuolation, and focal loss (curved arrows), of the microvillus border (my). By comparison,
this albumin-perfused tubule (B) was normal in appearance. In this section, the microvillus (my) borders are in apposition. (Uranyl acetate and lead
citrate, original magnification x2,750).
presence of osmotically active impurities in their BJP preparation.
The time-dependent decrease in solute transport is also important
in the understanding of the mechanism of cell toxicity of BJP.
We chose albumin as the control protein because its handling
by the PCT has been extensively studied [24—27], it does not
alter water absorption of tubules in vivo [23], it is partially
filterable, and it is absorbed and catabolized to amino acids in
the PCT within six minutes [27]. Our data confirm the lack of
toxicity of intraluminal albumin since perfusion of nephrons
with albumin, 5 gIdl, did not alter PCT function and morphol-
ogy. In addition to albumin, we have also used the BJP as its
own control and showed that PCT function was not immedi-
ately altered by the perfusate containing the BJP. At this time,
however, we cannot state that this toxicity is specific for light
chains and in fact may occur with other low molecular-weight
proteins such as myoglobin and beta-lactoglobulin [8, 9].
Morphologic clues of early nephrotoxic cell damage—in-
creased endocytic activity, vacuolation and focal loss of the
brush border [41]—were prominent findings in the proximal
tubules of those nephrons perfused with the BJP compared to
those perfused with albumin. In the PCT's of the BJP-perfused
tubules, the lysosomes were enlarged, increased in number, and
several were distorted (Figs. 3, 4B, 5, and 6). Focal loss of the
brush border of several cells of the epithelium of the PCT was
identified (Figs. 3, 4A, and 6B). In addition to these findings, the
majority of the BJP-perfused tubules had fragmentation and
desquamation of cells (Figs. 1 and 2) or cytoplasmic compo-
nents (Fig. 6A) into their lumens. Therefore, the functional and
morphologic studies are complementary and show that a human
Bence Jones protein can produce an acute injury to the epithe-
hum of the PCT of the rat in vivo.
How BJP's produce cell damage is not certain. Clinically, not
all patients with Bence Jones proteinuria have renal failure;
some patients may excrete large amounts of BJP without
evidence of renal damage [42]. It is possible that, because of
their physiochemical properties, nontoxic BJP's are filtered but
are poorly absorbed by the proximal tubule. Alternatively,
nontoxic BJP's are absorbed and readily catabolized by the
proximal tubule while toxic BJP's or their intermediate cata-
bolic products such as amyloid are not readily degraded in the
lysosomes. For example, in an acid milieu (pH 4.5 to 5.0)
comparable to that of the lysosome [43], some, but not all,
BJP's have been shown to precipitate during incubation in vitro
with the lysosomal fraction of homogenated human kidney
tissue [44]; catabolism of these aggregated proteins may be
impaired. Similarly, proteolytic cleavage of some BJP's has
produced polymerization of the amino terminal fragments into
amyloid, which has also been found in lysosomes of macro-
phages and is thought to be the result of intralysosomal diges-
tion [45]. Indirect evidence of precipitation of BJP or interme-
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Fig. 4. Electronmicrographs of 2 BJP-perfused PCT's. Figure 4A shows activation of the lysosomal system (curved arrows) and cytoplasmic
protrusion on the luminal side of one cell where the microvillus border (my) is absent (arrows). (Uranyl acetate and lead citrate, original
magnification x2,750). Figure 413 shows several markedly enlarged, distorted tysosomes (arrows) of a PCT cell and apical vacuolation (V). (Uranyl
acetate and lead citrate, original magnification x2,750).
diate catabolic product is suggested by a study by Clyne et a!
[46], who injected rats intraperitoneally with a human, kappa
light chain and noted development of tubular proteinuria within
12 hours. Electron microscopy of the proximal tubules of these
rats revealed many polygonal dense bodies, some of which had
a crystalline appearance; several degenerative changes of the
tubule cells were found [46]. The result of impaired degradation
of BJP may be an overwhelming or "clogging" of the lysosomal
system [47]. In turn, lysosomal overload could cause release of
their digestive enzymes which may manifest as cytoplasmic
vacuolatjon [47, 48]. Since some phagocytic cells internalize up
to 186% of their surface area and 25% of their cell volume per
hour [43, 49], this process could also diminish return of plasma
membrane to the surface of the cell. The combination of
lysosomal dysfunction, release of digestive enzymes into the
cytoplasm, and decreased plasma membrane availability and
turnover would cause reduced cell function and eventual cell
death. The present study supports this hypothesis of lysosome
overload by showing localization of BJP in an activated lyso-
somal system of the PCT cells. Some of the lysosomes were
atypical and appeared to contain crystals (Fig. SC). These
changes occurred at a time when other morphologic alterations
of the PCT cells were observed and volume and glucose
absorption by the proximal convolution was impaired. Further
study of this proposed mechanism is indicated.
Another physicochemical property of BJP's—the isoelectric
point (p1)—has been considered by some authors [12, 50] to be
an important factor conferring nephrotoxocity. Other studies
[8, 10, 51—53] have shown no correlation between nephrotoxic-
ity and the p1 of the BJP. Other proteins that include lysozyme
(p1, 11.0) [54] and cationized albumin (p1 8.4) [25] have been
shown to damage renal tubules, but the p1's of these proteins
are very high. By comparison, our BJP had a p1 of 7.7. At pH
7.4 (the pH of our perfusate), this protein possesses a net
positive charge, which may facilitate absorption of the protein
and therefore accelerate toxicity. Thus, the p1 of the BJP may be
an important determinant of nephrotoxicity.
In conclusion, we have shown that a human kappa light chain
is absorbed by endocytosis and produces an acute toxic injury
in cells of the rat proximal convoluted tubule. Since some BJP's
are not nephrotoxic [5, 42], perfusion of the PCT with a variety
of BJP's may allow in vivo characterization of the nephrotoxic
potential of each BJP and subsequent correlation between
toxicity and the physicochemical property(s) of that protein.
Although these results cannot be extrapolated directly to renal
failure in human multiple myeloma, it is possible that this
toxicity of BJP's not only directly impairs nephron function but
also diminishes absorption of the BJP by the proximal tubule,
allowing increased delivery of the protein to the distal nephron
where the acid pH, lower tubule fluid flow rate, and Tamm-
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Fig. 5. Immunoelectron micrographs using an antikappa antibody stain, demonstrating several abnormal lysosomes of the BJP-perfused PCT's.
Alteration of the lysosomal system was prominent in these tubules and was not seen in the albumin-perfused nephrons. A shows an enlarged
lysosome (L) (Uranyl acetate and lead citrate, original magnification x 16,500). B shows evidence of autophagia of the cell with the presence of
cytoplasmic organelles in a lysosome (center) (Uranyl acetate and lead citrate, original magnification x6,000). C shows a markedly enlarged,
distorted lysosme (L) which contains structures resembling crystals and is surrounded by numerous smaller lysosomes, some of which are merging
with it (Uranyl acetate and lead citrate, original magnification x7,700). The lysosomes in these figures stain with the anti-kappa antibody that is
linked to colloidal gold (seen as small black dots).
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Fig. 6. Immunoelectron micrographs of two other BJP-perfused PCT's, demonstrating kappa labeling of the endosomes and lysosomes (clear
arrows) of the cells of the PCT. The mitochondria (curved allows) and other organelles of the cell are not labeled to a significant degree. In addition
to activation of the lysosomal system with enlargement and atypical appearance of the lysosomes (L), vacuolation (V) and desquamation of cell
fragments (solid arrows) into the lumen are noted (A) Uranyl acetate and lead citrate, original magnification x5,000). B also shows loss of the
microvillus border (my) (Uranyl acetate and lead citrate, original magnification X6,000).
Horsfall glycoprotein facilitate BJP aggregation and allow cast
formation which, in turn, further decreases nephron function.
In addition, desquamation of proximal tubule cells and cell
fragments may contribute to the tubular obstruction. Thus,
dysfunction of the proximal tubule may be the first event to
occur in the development of the tubulointerstitial nephropathy
of multiple myeloma.
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